// App-Quantinova.ai

1811 : Evaluation of Antiplatelet and Anticoagulation Therapy in High-Risk COVID-19 Patients

Researchers

Presenter

  • Farah Ashraf

Principal Investigators

  • Anita Mazloom

  • Neil Nimkar

  • Nisha Patel

  • Amardeep Kalsi

  • Angelica Singh

  • Sonal Paul

  • Nivetha Vishnuvardhan

  • Abeer Ashfaq

  • Soeb Usta

  • Rich Kodama

  • Chathula Kumarasinghe

  • Peter Gregos

  • Jeremy Weingarten

  • Uqba Khan

  • Eshan Patel

Medical Centers

  • New York - Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY

  • New York - Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY

  • New York-Presbyterian Brooklyn Methodist Hospital, New Rochelle, NY

  • New York - Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY

  • New York Presbyterian, 506 6th St, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Venous thrombosis

  • Myocardial infarction

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • dipyridamole

  • rivaroxaban

  • Clopidogrel bisulfate

  • Enoxaparin

  • Enoxaparin sodium

  • Ticagrelor

  • Prasugrel

  • apixaban

  • Methadone hydrochloride

  • Warfarin

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved